RBS earnings: what can we expect?

Next week sees Royal Bank of Scotland publish its full-year results, but it would be wise not to expect too much from this shrunken titan of the pre-2008 world.

RBS is the bank that hasn’t moved on. That might sound cruel, but when compared with peer Lloyds – also rescued by the taxpayer in the dark days of 2008 – the bank is still a long way from returning to health.

The share price performance is the clearest indication of this. Over the past year alone, Lloyds is up 44.5%, compared to an RBS share price that has barely budged; up 0.08%. Since the beginning of 2012, the figures are better, with RBS returning 77%. Over the same period, however, Lloyds is up 228%. When you consider that the government has already begun selling its stake in Lloyds, the difference is even starker.

In terms of next week’s results, investors should look out for any increase in litigation payments, after the recent update showed that the board had set aside £1.9 billion. There are also PPI claims and other mis-selling claims to consider, which are unlikely to disappear soon.

RBS is expecting a return-to-profit, but this does not mean the bank is out of the woods yet. Its investment banking division still has a giant question mark hovering over it, with any sale likely to cost the bank a sizeable sum. Meanwhile, political interference makes long-term decision-making difficult.

The RBS share price appears to have hit resistance for the time being around 360p, and could see sustained weakness ahead of next week. Expectations are fairly limited for the results, which leaves open the possibility of some sort of rally, and for now I would incline towards a cautious ‘buy’ for the shares, given that they remain in the uptrend that began back in summer 2012.

RBS chart

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

CFD’s zijn complexe instrumenten en brengen vanwege het hefboomeffect een hoog risico mee van snel oplopende verliezen. 79% van de retailbeleggers lijdt verlies op de handel in CFD’s met deze aanbieder.
Het is belangrijk dat u goed begrijpt hoe CFD's werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
CFD’s zijn complexe instrumenten en brengen vanwege het hefboomeffect een hoog risico mee van snel oplopende verliezen.